Daniel H. Ahn
Impact in
Papers in
- Co-authors
- Tanios Bekaii‐Saab (76 shared papers)Glyn Johnson (2 shared papers)Stanley Lu (2 shared papers)Mitesh J. Borad (33 shared papers)Soonmee Cha (1 shared paper)Milind M. Javle (9 shared papers)Rachna T. Shroff (5 shared papers)Ahmed Omar Kaseb (3 shared papers)
- Journals
- The Oncologist (11 papers)Annals of Oncology (10 papers)Cancers (6 papers)Future Oncology (6 papers)JCO Precision Oncology (5 papers)
- Partner nations
- United StatesBrazilSpain
In The Last Decade
Daniel H. Ahn
119 papers receiving 4.6k citations
Daniel H. Ahn's Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 1.2k
- Surgery 1.6k
- Genetics 250
- Hepatology 246
- Radiology, Nuclear Medicine and Imaging 468
Countries citing papers authored by Daniel H. Ahn
This map shows the geographic impact of Daniel H. Ahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Ahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Ahn more than expected).
Fields of papers citing papers by Daniel H. Ahn
This network shows the impact of papers produced by Daniel H. Ahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Ahn. The network helps show where Daniel H. Ahn may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel H. Ahn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 124 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Futibatinib for FGFR2 -Rearranged Intrahepatic Cholangiocarcinoma Hit paper breakdown → | 2023 | 415 |
| 2 | Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers Hit paper breakdown → | 2019 | 376 |
| 3 | Biliary cancer: Utility of next‐generation sequencing for clinical management Hit paper breakdown → | 2016 | 342 |
| 4 | Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. | 2003 | 325 |
| 5 | 2004 | 277 | |
| 6 | 2019 | 226 | |
| 7 | 2022 | 183 | |
| 8 | 2020 | 164 | |
| 9 | 2018 | 146 | |
| 10 | 2016 | 131 | |
| 11 | 2015 | 107 | |
| 12 | 2017 | 103 | |
| 13 | 2014 | 91 | |
| 14 | 2019 | 86 | |
| 15 | 2015 | 78 | |
| 16 | 2019 | 73 | |
| 17 | 2015 | 69 | |
| 18 | 2018 | 61 | |
| 19 | 2021 | 60 | |
| 20 | 2019 | 59 |
About Daniel H. Ahn
Daniel H. Ahn is a scholar working on Oncology, Surgery, Hepatology, Cancer Research and Pathology and Forensic Medicine, having authored 124 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (36 papers), Pancreatic and Hepatic Oncology Research (22 papers), Colorectal Cancer Treatments and Studies (20 papers), Cancer Immunotherapy and Biomarkers (7 papers), Genetic factors in colorectal cancer (7 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cancer Genomics and Diagnostics (7 papers) and Colorectal Cancer Surgical Treatments (4 papers). The work is most often cited by research in Oncology (1.2k citations), Surgery (1.6k citations), Genetics (250 citations), Hepatology (246 citations) and Radiology, Nuclear Medicine and Imaging (468 citations). Daniel H. Ahn has collaborated with scholars based in United States, Brazil and Spain. Frequent co-authors include Tanios Bekaii‐Saab, Glyn Johnson, Stanley Lu, Mitesh J. Borad, Soonmee Cha, Milind M. Javle, Rachna T. Shroff, Ahmed Omar Kaseb, Mohamad Bassam Sonbol and David Zagzag. Their work appears in journals such as The Oncologist, Annals of Oncology, Cancers, Future Oncology and JCO Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.